Dr. Sandip Patel, MD
Claim this profileUC San Diego Moores Cancer Center
Studies Solid Tumors
Studies Non-Small Cell Lung Cancer
18 reported clinical trials
26 drugs studied
Area of expertise
1Solid Tumors
Stage IV
Stage III
HLA-A positive
2Non-Small Cell Lung Cancer
Stage IV
Stage III
ROS1 negative
Affiliated Hospitals
Clinical Trials Sandip Patel, MD is currently running
FL115
for Cancer
First-in-Human, Phase I, open-label, multicenter, dose-escalation study to evaluate the safety, tolerability, PK, pharmacodynamics, and preliminary antitumor activity of FL115 in patients with advanced solid tumors who have progressed or are intolerant to current standard-of-care therapies, including immune check-point inhibitors administered in single-agent or combination use.
Recruiting1 award Phase 112 criteria
A2B530 CAR T Therapy
for Solid Cancers
This trial tests A2B530, a treatment using modified immune cells from the patient, in adults with hard-to-treat cancers like colorectal, pancreatic, and lung cancer. The treatment aims to target and kill cancer cells while protecting healthy cells.
Recruiting1 award Phase 1 & 27 criteria
More about Sandip Patel, MD
Clinical Trial Related2 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 11 Active Clinical TrialsTreatments Sandip Patel, MD has experience with
- Nivolumab
- Pembrolizumab
- Ipilimumab
- PRO1184
- BMS-986406
- Tislelizumab
Breakdown of trials Sandip Patel, MD has run
Solid Tumors
Non-Small Cell Lung Cancer
Cancer
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sandip Patel, MD specialize in?
Sandip Patel, MD focuses on Solid Tumors and Non-Small Cell Lung Cancer. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are Stage III.
Is Sandip Patel, MD currently recruiting for clinical trials?
Yes, Sandip Patel, MD is currently recruiting for 10 clinical trials in La Jolla California. If you're interested in participating, you should apply.
Are there any treatments that Sandip Patel, MD has studied deeply?
Yes, Sandip Patel, MD has studied treatments such as Nivolumab, Pembrolizumab, Ipilimumab.
What is the best way to schedule an appointment with Sandip Patel, MD?
Apply for one of the trials that Sandip Patel, MD is conducting.
What is the office address of Sandip Patel, MD?
The office of Sandip Patel, MD is located at: UC San Diego Moores Cancer Center, La Jolla, California 92093 United States. This is the address for their practice at the UC San Diego Moores Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.